Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 1997

View Archived Issues

AGE inhibitors reported by Kissei

Novel antiarrhythmic agents described by Merck & Co.

Anticancer agents from Takeda

Pfizer claims 5-LO inhibitors

Sugen reports modulators of tyrosine signal transduction

Neutrophil-stimulating peptides derived from TNF described by Peptech

PPL reports progress in transgenic cow program

Alza obtains rights to opioid analgesic and licenses the product to Knoll

U.S. patent covers DLK gene

FDA approves product for hemophilia

Encouraging phase IIb results for antiparkinsonian patch

ABS moves to Boston

IND filed for novel HIV treatment from Steroidogenesis Inhibitors

Orphan Medical expands clinical trials of Busulfanex

Harvard Scientific's impotence drug advances in European trials

Patent coverage for lung cancer detection technology

Supplemental NDA filed for Photofrin

Penederm receives U.K. marketing approval for topical acne treatment

Basal lamina-based drugs offer promise for tumor metastasis

Lilly/Taisho sign technology transfer agreement

Idec acquires rights to anticancer agent

DiagnoCure prepares for clinical trials of bladder cancer diagnostic

Paroxetine inhibits NOS

Valproate efficacy in major depressive disorder

ICOS' Hu23F2G enters phase II

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...